These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 29580194

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Postlicensure safety surveillance for varicella vaccine.
    Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR.
    JAMA; 2000 Sep 13; 284(10):1271-9. PubMed ID: 10979114
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Safety of Second-Dose Single-Antigen Varicella Vaccine.
    Su JR, Leroy Z, Lewis PW, Haber P, Marin M, Leung J, Woo EJ, Shimabukuro TT.
    Pediatrics; 2017 Mar 13; 139(3):. PubMed ID: 28174201
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Adverse events after vaccination among HIV-positive persons, 1990-2016.
    Su JR, Ng C, Lewis PW, Cano MV.
    PLoS One; 2018 Mar 13; 13(6):e0199229. PubMed ID: 29920551
    [Abstract] [Full Text] [Related]

  • 30. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.
    Moro PL, Woo EJ, Marquez P, Cano M.
    Vaccine; 2020 Aug 18; 38(37):5923-5926. PubMed ID: 32709434
    [Abstract] [Full Text] [Related]

  • 31. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J, Weinke T, Garcia de Lomas J, Meyer CU, Bertrand I, Eymin C, Thomas S, Sadorge C.
    Vaccine; 2015 Feb 04; 33(6):789-95. PubMed ID: 25555381
    [Abstract] [Full Text] [Related]

  • 32. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
    McGirr A, Van Oorschot D, Widenmaier R, Stokes M, Ganz ML, Jung H, Varghese L, Curran D.
    Appl Health Econ Health Policy; 2019 Oct 04; 17(5):723-732. PubMed ID: 31250218
    [Abstract] [Full Text] [Related]

  • 33. Safety of live attenuated herpes zoster vaccine in adults 70-79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program.
    Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K.
    Vaccine; 2020 May 13; 38(23):3968-3979. PubMed ID: 32284271
    [Abstract] [Full Text] [Related]

  • 34. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
    Miller G, Schaefer H, Yoder S, Miller R, Winokur P, Kotloff K, Klassen D, Wierzbicki M, Amegashie C, Edwards K.
    Transpl Infect Dis; 2018 Jun 13; 20(3):e12874. PubMed ID: 29512282
    [Abstract] [Full Text] [Related]

  • 35. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
    Mills R, Tyring SK, Levin MJ, Parrino J, Li X, Coll KE, Stek JE, Schlienger K, Chan IS, Silber JL.
    Vaccine; 2010 Jun 07; 28(25):4204-9. PubMed ID: 20416263
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Safonova E, Yawn BP, Welte T, Wang C.
    Respir Res; 2023 Jan 28; 24(1):35. PubMed ID: 36709298
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.